TARO Key Stats
- Indian shares snap four-day losing streak; GDP, flows on watch 7:15 AM
- Sensex ends four-day losing streak; Tata Steel gains 6:12 AM
- Sun Pharma falls after unit's earnings disappoint 1:33 AM
- Taro Pharmaceutical Industries Ltd. (TARO) Reports Q1 EPS of $1.10 Street Insider May 23
- Taro Provides Results Year Ended March 31, 2013 Business Wire May 23
- Q4 2013 Taro Pharmaceutical Industries Ltd Earnings Release - After Market Close May 23
- BlueMountain Capital Is Bullish On These 5 Stocks Fool May 22
- Taro to Announce Results for Year Ended March 31, 2013 Business Wire May 16
- Antibodies Show Higher Probability of Success and a Higher Rate of M&A: Learn Wh... May 3
- My Thoughts On Taro Apr 14
TARO Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Taro Pharmaceutical Industries is up 46.40% over the last year vs S&P 500 Total Return up 27.81%, Perrigo Company up 17.85%, and Valeant Pharmaceuticals International up 81.01%.
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Income Statement View Statement
Pro Ratings for TARO
Pro Report PDF for TARO
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.Download TARO Pro Report PDF
Pro Strategies Featuring TARO
Did Taro Pharmaceutical Industries make it into our Pro Portfolio Strategies?